

Author: Shorey Ryan C.
Publisher: Informa Healthcare
ISSN: 1606-6359
Source: Addiction Research and Theory, Vol.21, Iss.2, 2013-04, pp. : 132-140
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content




Epoetin alfa for retinal disorders?
Inpharma, Vol. 1, Iss. 1369, 2003-01 ,pp. :


Roxithromycin for preventing coronary disorders?
Inpharma, Vol. 1, Iss. 1430, 2004-01 ,pp. :


SF-36: a `therapeutic tool' in patients with eating disorders?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 301, 2001-01 ,pp. :


Potential for prenylation inhibitors in renal disorders?
Inpharma, Vol. 1, Iss. 1227, 2000-01 ,pp. :